This inventor holds 2 USPTO granted patents. Top assignee: Forma Therapeutics, Inc.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: The Innovative Contributions of Stephen Hubbs
Introduction
Stephen Hubbs is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on the development of solid forms of complex chemical compounds, which are crucial for various therapeutic applications.
Latest Patents
Hubbs' latest patents include innovative formulations of solid forms of the compound 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone. These patents detail the solid forms of this compound, which are essential for enhancing the stability and efficacy of pharmaceutical products.
Career Highlights
Stephen Hubbs is currently employed at Forma Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical innovation. His expertise in chemical formulations has made him a valuable asset to the company and the industry at large.
Collaborations
Throughout his career, Hubbs has collaborated with talented professionals, including George P. Luke and Matthew W. Martin. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical sector.
Conclusion
Stephen Hubbs exemplifies the spirit of innovation in the pharmaceutical industry through his patents and collaborations. His work continues to impact the field positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile